Struma ovarii is a rare ovarian growth made mostly of thyroid tissue, and it most often affects adults. Early symptoms of struma ovarii can be easy to miss and may include belly or pelvic pain, bloating, or a feeling of pressure. Some people with struma ovarii also have an ovarian mass, and a few develop signs of an overactive thyroid. It may help to know that doctors have studied this condition for decades, and treatment is usually surgery, with other care depending on whether the growth is benign or cancerous. The outlook is often good when struma ovarii is benign, while the small number of malignant cases need closer follow-up and sometimes additional treatment.
How many people live with Struma ovarii?
Global and U.S. prevalence estimates for struma ovarii are not consistently reported by a single authoritative source, so there is no reliable published count of how many people are living with it worldwide or in the United States. It is generally described as extremely rare, making up about 0.5% to 1% of all ovarian tumors and about 2% to 5% of ovarian teratomas, based on widely cited estimates from sources such as StatPearls and case-series reviews.
Overview
Struma ovariiSymptoms
Struma ovarii often causes no symptoms at first. When it does, people may notice pelvic pain, bloating, a feeling of fullness, or a pelvic mass. Some also have irregular bleeding, and rarely, signs of an overactive thyroid.
Outlook and prognosis
Most people with struma ovarii do very well after treatment, especially when it is benign and limited to one ovary. Recovery is often complete. If it is cancerous, outlook is still often favorable with specialist care and follow-up.
Causes and risk factors
Struma ovarii usually arises sporadically from a germ cell growth in the ovary. Clear environmental or lifestyle risk factors are not known. It can occur at any adult age, most often during reproductive years.
Genetic influences
Genetics usually do not play a major role in struma ovarii, and most cases happen sporadically. Routine genetic testing is not standard, although rare malignant struma ovarii can carry gene changes also seen in some thyroid cancers.
Diagnosis
Struma ovarii is usually diagnosed after an ovarian mass is found on pelvic imaging, often ultrasound or CT. The diagnosis of struma ovarii is confirmed by examining tissue after surgery, with blood tests sometimes helping rule out thyroid overactivity.
Treatment and drugs
Struma ovarii is usually treated with surgery to remove the ovarian growth, often while preserving as much healthy ovary as possible. If it acts like thyroid tissue or proves cancerous, treatment may include thyroid testing, thyroid surgery, or radioactive iodine.
Symptoms
Struma ovarii often causes no symptoms at first, so it may be found during a scan or surgery done for something else. When early symptoms of Struma ovarii do show up, they usually feel like pressure or discomfort in the lower belly or pelvis, much like other ovarian growths. A smaller number of people develop signs of an overactive thyroid because the growth contains thyroid tissue. Symptoms vary from person to person and can change over time.
Many people feel completely well, especially when the growth is small. In those cases, Struma ovarii may only come to light during an ultrasound, CT scan, or an operation for another reason.
Dull aching, cramping, or one-sided pain in the pelvis or lower belly is common. The discomfort may come and go at first, then become more noticeable as the ovary stretches or nearby tissue is pressed.
The abdomen may feel bloated, tight, or uncomfortably full even after a light meal. Some people notice a heavy feeling in the lower belly or that clothes fit more snugly around the waist.
When the mass presses on the bladder or bowel, it can cause frequent urination, constipation, or a constant sense of pressure low in the pelvis. These symptoms can happen with many ovarian masses and are not unique to Struma ovarii.
How people usually first notice Struma ovarii?
Struma ovarii is usually first noticed when a person develops vague pelvic or lower belly symptoms that do not go away, such as pain, pressure, bloating, or a feeling of fullness, and an ultrasound or CT scan then shows an ovarian mass. Many people with the first signs of struma ovarii do not have obvious symptoms at all, so it may also be found during surgery or imaging done for another reason. Less often, how struma ovarii is first noticed is through symptoms of an overactive thyroid, such as a racing heartbeat, sweating, nervousness, or unexplained weight loss, because this rare ovarian tumor can contain thyroid tissue that makes thyroid hormone.
Types of Struma ovarii
Struma ovarii can affect daily life in different ways, from causing no clear problems to leading to belly swelling, pelvic discomfort, or signs of an overactive thyroid. Symptoms don’t always look the same for everyone. In practice, the main types of struma ovarii are usually described by whether the growth is benign or malignant, and whether it produces thyroid hormone. These differences can shape how symptoms show up and how closely doctors need to monitor it.
Benign struma ovarii
This is the most common form and is not cancer. Many people have no symptoms at first, while others notice pelvic pain, bloating, a feeling of pressure, or a mass found during imaging or surgery. It may also cause fluid buildup in the belly, and sometimes around the lungs, even when the tumor is not malignant.
Malignant struma ovarii
This is a rare cancerous form in which the thyroid-type tissue shows cancer changes. Symptoms can look similar to benign struma ovarii at first, such as pelvic pain, abdominal swelling, or a growing ovarian mass, so the difference is often confirmed after surgery and lab testing. Among the types of struma ovarii, this variant is more likely to need longer follow-up because it can spread or come back.
Functioning struma ovarii
In this variant, the tumor makes thyroid hormone, which can lead to symptoms of hyperthyroidism. Some may notice a fast heartbeat, sweating, shakiness, weight loss, heat intolerance, or feeling unusually anxious along with pelvic symptoms or no pelvic symptoms at all. Having hormone-related symptoms does not by itself mean the tumor is cancerous.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in struma ovarii, which is a rare ovarian growth. Research on prevention is very limited, and things like diet, exercise, sleep, or supplements have not been shown to stop it from starting, even though they are still good for overall health. There are no well-established screening tests or preventive medicines for most people, but getting checked early for ongoing pelvic pain, bloating, a new belly lump, or signs of an overactive thyroid can help it be found and treated sooner, which may lower complications without preventing the condition.
What genetics can tell you about symptoms
For struma ovarii, genetics usually do not tell doctors much about which symptoms someone will have, how severe they will be, or when they will start. Most symptoms are linked more to what the growth is doing, such as causing pelvic pain, bloating, an ovarian mass, or, less often, making thyroid hormone and triggering symptoms like a racing heartbeat or weight loss. In the uncommon cancerous form, some tumors can carry gene changes similar to those seen in thyroid cancer, but these findings are not yet used to reliably predict day-to-day symptoms for most people living with struma ovarii.
Causes and risk factors
Struma ovarii usually starts when thyroid tissue grows inside an ovarian teratoma. The exact causes of struma ovarii are not fully understood, and most cases seem to happen by chance. It is found most often in adults during the reproductive years or around midlife, so age may be one biological risk factor. Most people do not have a known inherited gene change, and no clear lifestyle or environmental risk factors have been proved. Researchers are still learning how these pieces fit together.
What are the most common causes or risk factors?
Doctors do not know a clear cause for struma ovarii, and there are no well-proven lifestyle or inherited risk factors for most people living with it. It is a rare ovarian growth that most often shows up in adults, especially between ages 30 and 50, and it usually develops within a type of ovarian lump that contains different kinds of body tissue. In the uncommon cases that act like cancer, doctors may find gene changes in the tumor itself, but these changes are usually not passed down in families.
Environmental and biological risk factors
Struma ovarii is a rare ovarian growth, and the risk factors for struma ovarii are not as well mapped out as they are for many more common conditions. Researchers are still exploring how outside influences interact with our inner biology. So far, age and the type of ovarian tissue it arises from are the clearest biological patterns, while no specific environmental exposure has been firmly linked to it.
Struma ovarii is most often diagnosed in adults during the reproductive years, especially from the 30s into the 50s. It can occur outside this age range, but age is one of the few recurring biological patterns reported.
Struma ovarii is a rare subtype of an ovarian teratoma, a growth that starts from germ cells in the ovary. This describes the biological setting where it develops, even though it does not fully explain why it happens.
No specific environmental exposure, infection, or medication has been clearly shown to increase the chance of struma ovarii. Most people diagnosed with it do not have an identifiable outside trigger.
Genetic risk factors
Most people with Struma ovarii do not have a clear inherited reason for developing it. Because this tumor is rare, the genetic causes of Struma ovarii are still not fully mapped, and most cases seem to happen sporadically rather than run in families. When cancer develops within Struma ovarii, doctors sometimes find gene changes similar to those seen in thyroid cancer, but these changes are usually limited to the tumor itself. Carrying a genetic change doesn’t guarantee the condition will appear.
Sporadic cases: Most Struma ovarii cases seem to happen by chance, without a known inherited mutation passed down in a family. Many people diagnosed with it do not have a family history that would have predicted it.
Germ cell origin: Struma ovarii starts in ovarian germ cells, which are cells that can develop into several tissue types. The important gene changes are thought to arise as the tumor forms in those cells, rather than being present in every cell of the body from birth.
Tumor-only mutations: In the small number of cases that are cancerous, the tumor may carry changes in growth-control genes also seen in thyroid cancer, including BRAF or RAS. These are usually somatic changes, which means they are found in the tumor itself and are not typically inherited.
Family pattern: There is no well-established hereditary syndrome or consistent family pattern known to strongly raise the risk of Struma ovarii. Having relatives with common thyroid disease does not clearly point to a higher genetic risk for this ovarian tumor.
Benign versus malignant: Genetic findings can differ between benign Struma ovarii and the rare malignant forms. No single gene change explains most cases, which is one reason this condition can behave differently from one person to another.
Lifestyle risk factors
There are no well-established lifestyle risk factors known to directly cause struma ovarii, and current evidence does not link it strongly to diet, exercise, or other daily habits in the way seen with many common chronic diseases. For people wondering about lifestyle risk factors for Struma ovarii, the main point is that lifestyle seems to have much more impact on overall health, symptom burden, and recovery from treatment than on whether the tumor develops. Even so, some habits can still matter indirectly, especially if surgery is needed or if thyroid-related symptoms occur.
Smoking has not been shown to specifically cause struma ovarii. However, it can worsen surgical risks, delay healing, and put extra strain on the heart if thyroid hormone excess is present.
Excess body weight is not a proven direct cause of struma ovarii. It may still increase anesthesia risk, reduce mobility during recovery, and make pelvic or abdominal symptoms harder to tolerate.
Low physical activity is not a confirmed cause of struma ovarii. Regular movement may help maintain fitness before surgery and support recovery afterward, especially by lowering deconditioning and clot risk.
No specific diet is known to trigger struma ovarii. Good overall nutrition can still support immune function, wound healing, and strength if treatment or surgery becomes necessary.
Risk prevention
Because struma ovarii is a rare ovarian growth, there is no proven way to prevent it from forming in the first place. For most people, prevention is really about lowering the chance of complications by catching it early, especially if new pelvic symptoms appear or thyroid-like symptoms do not make sense otherwise. Prevention isn’t about perfection, it’s about small steps that add up.
Regular gynecology visits can help new ovarian masses get noticed sooner, sometimes before they cause bigger problems. This matters with struma ovarii because early assessment may lower the risk of pain, torsion, or delays in treatment.
Paying attention to early symptoms of struma ovarii, such as ongoing pelvic pain, bloating, belly swelling, or a feeling of pressure, can help you seek care sooner. Some people also notice unusual bleeding or symptoms that seem more like an overactive thyroid, such as palpitations, tremor, or unexplained weight loss.
If pelvic symptoms keep coming back or a doctor feels an ovarian mass, an ultrasound and follow-up testing can help clarify the cause. With struma ovarii, timely imaging may reduce the chance that a growing mass is missed until it causes complications.
When thyroid blood tests are abnormal without a clear reason, it is worth asking whether the ovaries should also be considered, especially if pelvic symptoms are present. In the uncommon cases where struma ovarii makes thyroid hormone, recognizing that link earlier can guide safer treatment.
Can you prevent Struma ovarii?
No, there is no known way to prevent struma ovarii. It is a rare type of ovarian growth that seems to happen unpredictably, and it is not known to be caused by everyday habits such as diet, exercise, or stress. Regular gynecologic care cannot prevent it, but it may help find an ovarian lump sooner if symptoms develop.
Transmission
Struma ovarii is not an infection, so it cannot be caught from someone else through close contact, sex, blood, food, or the air. If you are living with Struma ovarii, there is no risk of passing it to a partner, child, or anyone around you in daily life.
People sometimes ask how Struma ovarii is inherited, but in most cases it is not thought to run in families and is not usually passed from parent to child. Instead, Struma ovarii usually develops sporadically as a rare ovarian growth, so its infectiousness is essentially none.
When to test your genes
For struma ovarii, routine genetic testing is usually not part of early detection or standard care. It may be worth discussing only if you have a strong family history of ovarian, breast, or related cancers, or if the tumor is malignant and your care team wants to clarify inherited cancer risk.
Diagnosis
Struma ovarii is usually suspected when an ovarian mass is found during a work-up for pelvic pain, bloating, or a feeling of pressure in the lower belly. Some people have no clear symptoms, and the first clue appears during imaging for something else or at surgery. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of struma ovarii usually combines imaging, lab tests, and confirmation by examining the tissue after surgery.
Doctors ask about pelvic pain, swelling, changes in periods, and symptoms of an overactive thyroid such as palpitations, shakiness, or heat intolerance. A detailed history helps connect everyday symptoms with the ovarian mass and guides the next tests.
A pelvic exam may help your doctor feel a mass or notice tenderness and fullness in the pelvis. This exam cannot confirm struma ovarii on its own, but it can support the need for imaging.
Ultrasound is usually the first imaging test used to look at the ovary and nearby structures. CT or MRI may be added if the mass is complex or if doctors need a clearer picture before treatment.
Blood tests may include thyroid hormone levels if symptoms suggest the mass is making thyroid hormone. Other lab tests may help rule out common causes of an ovarian mass, although no blood test alone can prove struma ovarii.
How is Struma ovarii diagnosed?
Doctors usually suspect struma ovarii when an ovarian growth is seen on imaging tests such as ultrasound, CT, or MRI, especially if it comes with lower belly pain, bloating, or signs of an overactive thyroid. Blood tests may check thyroid hormone levels and other markers, but these tests alone cannot confirm the diagnosis. In most cases, the diagnosis is confirmed only after surgery or a small tissue sample is examined under a microscope and shows that much of the growth is made of thyroid tissue; genetic testing is not usually needed.
Stages of Struma ovarii
Struma ovarii does not have defined progression stages. This is because it is usually identified as a specific type of ovarian growth, rather than a condition that predictably moves through mild, moderate, and severe phases over time. Often the process begins when you notice changes in daily life, such as ongoing pelvic discomfort, bloating, or an ovarian mass found during imaging, and the early symptoms of struma ovarii can look like those of other ovarian conditions. Doctors usually confirm it with pelvic imaging, surgery, and laboratory examination of the tissue, while follow-up depends on whether it is benign or, more rarely, shows cancerous changes.
Outlook and prognosis
The outlook for struma ovarii is generally excellent, because most cases are benign and are cured with surgery alone. Recurrence is uncommon after complete removal of a benign tumor, and long-term survival is expected. Prognosis is more guarded when the tumor is malignant, especially if there is spread beyond the ovary, but even malignant struma ovarii often has a favorable outcome compared with many other ovarian cancers when treated appropriately with surgery and, in selected cases, thyroid-directed therapy such as radioactive iodine. Death from benign struma ovarii is exceedingly rare. For malignant disease, reported survival is usually high, although the risk of recurrence can persist for years, so prolonged follow-up is often recommended.
Long-term effects
For most people, struma ovarii has a very good outlook, especially when it is found early and removed with surgery. Many living with struma ovarii recover fully and do not have lasting health problems, although follow-up may still be needed because a small number of cases can come back or behave more aggressively. Thinking about the long-term effects helps set expectations after treatment and can make later checkups feel more purposeful.
Most struma ovarii tumors are benign, and long-term survival is usually excellent after treatment. Many people go back to normal daily life once they have recovered from surgery.
In a small number of people, struma ovarii can return after treatment, sometimes years later. Because of this, doctors may recommend follow-up visits and imaging over time.
Rarely, struma ovarii makes thyroid hormone, which can lead to ongoing symptoms such as palpitations, sweating, weight loss, or feeling shaky until the tumor is treated. After treatment, these hormone-related problems usually improve.
A small minority of struma ovarii cases are cancerous or later show cancer-like behavior. When that happens, the long-term outlook depends on whether the disease stays in the ovary or spreads elsewhere.
How is it to live with Struma ovarii?
Living with struma ovarii can feel confusing because it often acts like two problems at once: an ovarian mass that may cause pelvic pain, bloating, pressure, or changes in periods, and in some people, thyroid hormone symptoms such as palpitations, sweating, tremor, or unexplained weight loss. Day to day, many people are most affected by discomfort, fatigue, medical appointments, and the stress of waiting for scans, surgery, or answers about fertility, although treatment is often effective and many cases are benign. For partners, family, and close friends, the biggest impact is usually emotional support and helping with practical needs during recovery, while also adjusting to the uncertainty that comes with a rare condition.
Treatment and drugs
Struma ovarii is usually treated with surgery, because the main goal is to remove the ovarian growth and confirm whether it is benign or cancerous. If the growth is small and appears noncancerous, some people may have surgery that preserves as much normal ovary as possible, while others need a larger operation depending on age, fertility plans, and what doctors find during surgery. Treatment often looks different for each person, and if struma ovarii is causing signs of an overactive thyroid, such as a racing heartbeat, sweating, or weight loss, doctors may use medicines before or after surgery to control those symptoms. When struma ovarii is cancerous, treatment can include more surgery and sometimes radioactive iodine, especially if there is concern that thyroid-type cells remain or have spread, and follow-up blood tests and scans may be part of long-term care.
Can you cure Struma ovarii?
In many cases, yes. Struma ovarii is a rare growth in the ovary made mostly of thyroid tissue, and when it is not cancer, surgery to remove it is often enough to cure it. If it is cancerous or has spread, some may need more treatment, such as additional surgery or radioactive iodine, which targets thyroid tissue, to lower the chance of it coming back.
Non-drug treatment
Struma ovarii is usually managed with procedures and follow-up care rather than day-to-day medicines. Managing this condition often starts with surgery, because treatment depends on whether the growth is causing symptoms, looks suspicious for cancer, or affects future fertility plans. Many living with struma ovarii do well after treatment, but the plan can differ if there are signs of overactive thyroid function or if the tumor is cancerous. In some cases, careful follow-up is also part of care, especially when checking for return of symptoms after surgery for struma ovarii.
Surgery is the main non-drug treatment for struma ovarii and is often used to remove the ovarian mass and confirm the diagnosis. Depending on age, fertility goals, and whether cancer is suspected, surgery may remove just the cyst or ovary, or involve a more extensive operation.
For people who hope to become pregnant, doctors may choose fertility-sparing surgery when it is safe to do so. This can help preserve the uterus and the other ovary while still treating the mass.
If the struma ovarii is cancerous, has spread, or comes back, some may need thyroid surgery followed by radioactive iodine treatment. This helps doctors track any remaining thyroid-type tissue and is part of treatment for malignant struma ovarii rather than for most benign cases.
Follow-up visits often include pelvic imaging and blood tests, especially after surgery for malignant disease or when early symptoms of struma ovarii were linked to thyroid hormone changes. Not every approach works the same way, so the timing and type of monitoring depend on the pathology results and your symptoms.
Your genes may have an impact on how drugs work for you
For most people with struma ovarii, treatment is mainly surgery rather than long-term medicine, so gene-based drug matching is not usually part of routine care. If the growth acts like thyroid cancer and more treatment is needed, such as thyroid-related medicine, people can respond a little differently, but there are no widely used, well-established genetic tests that clearly guide medication choice specifically for struma ovarii. In everyday care, doctors usually adjust treatment based on how the tumor behaves, thyroid blood test results, and how someone is feeling, rather than on inherited gene differences.
Pharmacological treatments
Most people with struma ovarii are treated mainly with surgery, so medicines are usually added only in certain situations. Drug treatment for struma ovarii depends on whether the thyroid tissue in the ovary is causing an overactive thyroid, whether thyroid hormone is low after treatment, or whether the growth is cancerous and needs extra therapy. Not everyone responds to the same medication in the same way.
Levothyroxine replaces thyroid hormone when levels are too low after surgery or after thyroid gland treatment. It may also be used to keep thyroid-stimulating hormone low in some people with malignant struma ovarii, because that hormone can encourage thyroid-type cells to grow.
Methimazole is usually the first medicine used when struma ovarii causes hyperthyroidism, and propylthiouracil may be used in selected situations. These drugs lower thyroid hormone production and can help settle symptoms before surgery or other treatment.
Propranolol or atenolol can quickly ease fast heartbeat, shaking, sweating, and anxiety linked to excess thyroid hormone. They do not treat the tumor itself, but they can make day-to-day symptoms more manageable while the main treatment is planned.
Iodine-131 may be used after surgery in malignant, recurrent, or spread-out struma ovarii, often after the thyroid gland has also been removed. This treatment for struma ovarii targets thyroid-type tissue left in the body and is usually guided by a specialist team.
Genetic influences
After hearing the diagnosis, many living with struma ovarii want to know whether struma ovarii is hereditary. It’s natural to ask whether family history plays a role. For most people with struma ovarii, there is no clear inherited gene change known to cause it, and it usually develops sporadically rather than being passed from parent to child. In the uncommon cases where struma ovarii becomes cancerous, the tumor can carry acquired gene changes similar to those seen in some thyroid cancers, including BRAF or RAS changes, but these are usually limited to the tumor and are not inherited. Because of this, routine genetic testing for relatives is not usually part of care. Doctors may look more closely at family history only if there are other signs of an inherited cancer syndrome or several related cancers in the family.
Is Struma ovarii genetic?
Genetics usually do not play a major role in struma ovarii, and most cases happen sporadically. Routine genetic testing is not standard, although rare malignant struma ovarii can carry gene changes also seen in some thyroid cancers.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and are simply part of normal human diversity. For many genes, having a variant connected to a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with struma ovarii, the biggest treatment question is usually whether surgery alone is enough or whether thyroid-type treatment is also needed. Unlike some conditions, struma ovarii is not usually treated based on inherited drug-response genes, and there is no routine pharmacogenetic test that predicts which medicine will work best. Genetics is only one factor, and in struma ovarii doctors mostly base treatment on whether the growth is benign or cancerous, whether it has spread, and whether it is making excess thyroid hormone. If the rare case is malignant, testing the tumor itself for changes seen in thyroid cancers, such as BRAF or RAS, may sometimes help doctors judge how closely it behaves like thyroid cancer and whether thyroid-cancer treatments should be considered. Medicines used around treatment, including thyroid hormone tablets after surgery and radioactive iodine in selected thyroid-cancer-like cases, are usually chosen by lab results and the overall treatment plan rather than by a person’s inherited genes. So when people ask about genetic testing for struma ovarii, it can matter in uncommon situations, but for most, it plays a much smaller role than surgery findings, pathology results, and follow-up care.
Interactions with other conditions
People with struma ovarii may also have thyroid-related problems, and that can blur the picture because symptoms such as a fast heartbeat, sweating, weight loss, or anxiety may look like an overactive thyroid even though the source is in the ovary. In a small number of cases, struma ovarii actually makes thyroid hormone, so someone may be treated at first as if they have a standard thyroid disorder until imaging or surgery shows what is really going on. Another important aspect is how it may link with other diseases. Many living with struma ovarii also need their doctors to check the thyroid gland itself, because thyroid nodules, goiter, autoimmune thyroid disease, or rarely thyroid cancer can exist at the same time. Struma ovarii can also cause fluid buildup in the belly, and sometimes around the lungs, which can make it resemble ovarian cancer or other abdominal illnesses on scans and during the early symptoms of struma ovarii. Because these overlaps are uncommon but important, care often works best when gynecology, endocrinology, and sometimes oncology coordinate the evaluation together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Struma ovarii?
Because struma ovarii can cause bloating, lower belly pain, or a lump near the ovary, it is often confused with more common problems such as ovarian cysts, endometriosis, growths in the uterus called fibroids, or ovarian cancer. If it also causes symptoms like a fast heartbeat, sweating, shakiness, or weight loss, it can look similar to an overactive thyroid as well.
History
Long before modern scans and lab tests, doctors and surgeons occasionally came across unusual ovarian growths that did not look like typical cysts or tumors. When these growths were examined more closely, some were found to contain tissue that looked strikingly like thyroid tissue, even though it was sitting in the ovary rather than the neck. That unusual finding gradually led to the condition now known as struma ovarii being recognized as a distinct, though uncommon, type of ovarian growth.
Early medical reports came from the late 19th and early 20th centuries, when pathologists began carefully describing what they saw under the microscope after surgery. At first, these cases were mostly medical curiosities: an ovarian mass removed for pain, swelling, or an unexpected finding during an operation would later turn out to be made largely of thyroid-type tissue. Because struma ovarii is rare, it took time for doctors to understand that it could sometimes act quietly and cause few symptoms, while in other cases it could lead to an enlarged abdomen, pelvic discomfort, or signs linked to thyroid hormone changes.
In recent decades, awareness has grown as imaging, blood tests, and modern pathology have made it easier to recognize struma ovarii before and after surgery. Doctors also came to understand that most cases are benign, while a small number can behave more like cancer and need closer follow-up. This shift mattered in everyday care: instead of treating every unusual ovarian mass the same way, teams could plan surgery and monitoring more carefully based on what was suspected.
The history of struma ovarii also reflects a broader change in medicine. Early descriptions relied almost entirely on what could be seen during surgery or under a microscope, but later research connected those findings with symptoms, hormone effects, and long-term outcomes. That has helped make today’s care more precise and less uncertain for people living with struma ovarii, especially when doctors are trying to explain what an unexpected ovarian mass might mean and what happens next.